ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 97 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q1 2018. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $264,000 | +125.6% | 22,236 | 0.0% | 0.01% | +133.3% |
| Q1 2019 | $117,000 | +67.1% | 22,236 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $70,000 | -48.1% | 22,236 | 0.0% | 0.00% | -25.0% |
| Q3 2018 | $135,000 | +14.4% | 22,236 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $118,000 | -8.5% | 22,236 | 0.0% | 0.00% | -20.0% |
| Q1 2018 | $129,000 | +65.4% | 22,236 | 0.0% | 0.01% | +66.7% |
| Q4 2017 | $78,000 | -3.7% | 22,236 | 0.0% | 0.00% | -25.0% |
| Q3 2017 | $81,000 | +44.6% | 22,236 | 0.0% | 0.00% | +33.3% |
| Q2 2017 | $56,000 | -6.7% | 22,236 | 0.0% | 0.00% | -25.0% |
| Q1 2017 | $60,000 | -6.2% | 22,236 | 0.0% | 0.00% | -33.3% |
| Q4 2016 | $64,000 | -29.7% | 22,236 | 0.0% | 0.01% | -14.3% |
| Q3 2016 | $91,000 | +30.0% | 22,236 | 0.0% | 0.01% | 0.0% |
| Q2 2016 | $70,000 | – | 22,236 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 6,552,068 | $14,218,000 | 8.03% |
| Versant Venture Management, LLC | 5,068,233 | $10,998,000 | 4.55% |
| K2 PRINCIPAL FUND, L.P. | 1,653,874 | $3,589,000 | 0.29% |
| RTW INVESTMENTS, LP | 7,483,757 | $16,240,000 | 0.24% |
| Avoro Capital Advisors LLC | 6,950,000 | $15,082,000 | 0.24% |
| Artal Group S.A. | 3,000,000 | $6,510,000 | 0.15% |
| ALGERT GLOBAL LLC | 231,490 | $502,000 | 0.07% |
| Virtus ETF Advisers LLC | 57,768 | $125,000 | 0.06% |
| Pinz Capital Management, LP | 53,600 | $116,000 | 0.05% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 100,000 | $217,000 | 0.05% |